Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.